Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Brivaracetam Tablet vs Dry Syrup in Healthy Japanese Males
NCT06312566Phase 1Completed
- Sponsor
- UCB
- Start
- Mar 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of brivaracetam in epilepsy (2 arms), sponsored by UCB. Primary endpoints: Maximum Plasma Concentration at Steady State at Day 3 and Area Under the Curve During a Dosing Interval at Steady State at Day 3. Started Mar 2024; status: completed.
02
Drugs
brivaracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT06312566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06312566.